13-cis-Retinoic acid in the treatment of recurrent glioblastoma multiforme

This publication has 21 references indexed in Scilit:

• Retinoic Acid Receptors Inhibit AP1 Activation by Regulating Extracellular Signal-Regulated Kinase and CBP Recruitment to an AP1-Responsive Promoter
  Molecular and Cellular Biology, 2002
• Agonists of the retinoic acid- and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cells
  Molecular Brain Research, 2001
• Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
  Annals of Oncology, 2001
• A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
  British Journal of Cancer, 2000
• Retinoic acid and 1,25-dihydroxyvitamin D3 inhibit tenascin-C expression in rat glioma C6 cells
  Journal of Neuroscience Research, 1999
• A phase II study of intravenous carboplatin for the treatment of recurrent gliomas
  Journal of Neuro-Oncology, 1994
• Retinoids Inhibit the Oxidative Modification of Protein Kinase C Induced by Oxidant Tumor Promoters
  Archives of Biochemistry and Biophysics, 1993
• Regulation by retinoic acid of ICAM-1 expression on human tumor cell lines
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1991
• Treatment of advanced squamous cell carcinoma of the head and neck with isotretinoin: a phase II randomized trial
  Investigational New Drugs, 1988
• Treatment of Advanced Squamous Cell Carcinoma of the Skin with Isotretinoin
  Annals of Internal Medicine, 1987